Dialyzers designed to increase internal filtration do not result in significantly increased platelet activation and thrombin generation

Nephron - Clinical Practice

Volumn 117, Issue 4, 2011, Pages

  Vernon, Katherine ^a   Peasegood, Joanne ^a   Riddell, Anne ^a   Davenport, Andrew ^b  

^a ROYAL FREE HOSPITAL   (United Kingdom)

^b ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

Dialyzer clotting; Haemodialysis; Platelet activation; Polyethersulphone; Polysulphone; Polyvinylpyrrolidone

Indexed keywords

BETA THROMBOGLOBULIN; BLOOD CLOTTING FACTOR 8; D DIMER; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; INTEGRIN; PADGEM PROTEIN; PROTHROMBIN; THROMBIN ANTITHROMBIN COMPLEX; THROMBOCYTE FACTOR 4; VON WILLEBRAND FACTOR;

ADULT; AGED; ARTICLE; ARTIFICIAL KIDNEY; CLINICAL ARTICLE; FEMALE; FIBRINOLYSIS; GLOMERULUS FILTRATION; HEMODIALYSIS PATIENT; HUMAN; LEUKOCYTE; MALE; PRIORITY JOURNAL; RENAL REPLACEMENT THERAPY; THROMBIN TIME; THROMBOCYTE; THROMBOCYTE ACTIVATION;

AGED; BLOOD COAGULATION; FEMALE; HEMODIALYSIS SOLUTIONS; HUMANS; MALE; MIDDLE AGED; PLATELET ACTIVATION; RENAL DIALYSIS; THROMBIN;

EID: 78149298714     PISSN: 16602110     EISSN: None     Source Type: Journal    
DOI: 10.1159/000319884     Document Type: Article

References (23)

1. Lowrie EG, Laird NM, Parker TF, Sargent JA: Effect of the haemodialysis prescription of patient morbidity: report from the National Cooperative Dialysis Study. N Engl J Med 1981; 305: 1176-1181. (Pubitemid 12237476)
2. Gotch FA, Sargent JA: A mechanistic analysis of the National Cooperative Dialysis Study (NCDS). Kidney Int 1985; 28: 526-534. (Pubitemid 15248043)
3. Parker TF 3rd, Husni L, Huang W, Lew N, Lowrie EG: Survival of haemodialysis patients in the United States is improved with a greater quantity of dialysis. Am J Kidney Dis 1994; 23: 670-680. (Pubitemid 24138420)
4. Consensus Development Conference Panel. Morbidity and Mortality of Renal Dialysis: an NIH Consensus Conference Statement. Ann Intern Med 1994; 121: 62-70.
5. Eknoyan G, Beck GJ, Cheung AK, Daugirdas JT, Greene T, Kusek JW, Allon M, Bailey J, Delmez JA, Depner TA, Dwyer JT, Levey AS, Levin NW, Milford E, Ornt DB, Rocco MV, Schulman G, Schwab SJ, Teehan BP, Toto R, Hemodialysis (HEMO) Study Group: Effect of dialysis dose and membrane flux in maintenance haemodialysis. N Engl J Med 2002; 347: 2010-2019. (Pubitemid 35461657)
6. Spalding EM, Chandna SM, Davenport A, Farrington K: Kt/V underestimates the haemodialysis dose in women and small men. Kidney Int 2008; 74: 348-355. (Pubitemid 352001247)
7. 2 -microglobulin levels predict mortality in dialysis patients: results of the HEMO study. J Am Soc Nephrol 2006; 17: 546-555.
8. Locatelli F, Martin-Malo A, Hannedouche T, Loureiro A, Papadimitriou M, Wizemann V, Jacobson SH, Czekalski S, Ronco C, Vanholder R, for the Membrane Permeability Outcome (MPO) Study Group: Effect of membrane permeability on survival of haemodialysis patients. J Am Soc Nephrol 2009; 20: 645-654.
9. Davenport A, Farrington K: Dialysis dose and survival in acute kidney injury and chronic dialysis. Lancet 2010; 375: 705-706.
10. Davenport A: The techniques of haemofiltration and haemodiafiltration. J Ren Nurs 2009; 1: 191-195.
11. Davenport A: Membrane designs and composition for haemodialysis, haemofiltration and haemodialfiltration: past, present and future. Minerva Urol Nefrol 2010; 62: 29-40.
12. Davenport A: Low-molecular-weight heparin as an alternative anticoagulant to unfractionated heparin for routine outpatient haemodialysis treatments. Nephrology (Carlton) 2009; 14: 455-461.
13. Frank RD, Weber J, Dresbach H, Thelen H, Weiss C, Floege J: Role of contact system activation in hemodialyzer-induced thrombogenicity. Kidney Int 2001: 60: 1972-1981. (Pubitemid 33000004)
14. Davenport A: Anticoagulation for continuous renal replacement therapy. Contrib Nephrol. Basel, Karger, 2004, vol 144, pp 228-238.
15. De Sanctis LB, Stefoni S, Cianciolo G, Colì L, Buscaroli A, Feliciangeli G, Borgnino LC, Bonetti M, Gregorini MC, De Giovanni P, Buttazzi R: Effect of different dialysis membranes on platelet function. A tool for biocompatibility evaluation. Int J Artif Organs 1996; 19: 404-410. (Pubitemid 26280957)
16. Stefoni S, Colì L, Cianciolo G, Donati G, Ruggeri G, Ramazzotti E, Pohlmeier R, Lang D: Inflammatory response of a new synthetic dialyzer membrane. A randomised crossover comparison between polysulfone and Helixone®. Int J Artif Organs 2003; 26: 26-32. (Pubitemid 36896246)
17. Salmon J, Cardigan R, Mackie I, Cohen SL, Machin S, Singer M: Continuous venovenous haemofiltration using polyacrylonitrile filters does not activate contact system and intrinsic system coagulation pathways. Intensive Care Med 1999; 23: 38-43. (Pubitemid 27067894)
18. Bouman CS, de Pont AC, Meijers JC, Bakhtiari K, Roem D, Zeerleder S, Wolbink G, Korevaar JC, Levi M, de Jonge E: The effects of continuous venovenous hemofiltration on coagulation activation. Crit Care 2006; 10:R150.
19. Ambuhl PM, Wuthrich RP, Korte W, Schmid L, Krapf R: Plasma hypercoagulability in haemodialysis patients; impact of dialysis and anticoagulation. Nephrol Dial Transplant 1997; 12: 2355-2364. (Pubitemid 27474619)
20. Movilli E, Brunori G, Camerini C, Vizzardi V, Gaggia P, Cassamali S, Scolari F, Parrinello G, Cancarini GC: The kind of vascular access influences the baseline inflammatory status and epoetin response in chronic haemodialysis patients. Blood Purif 2006; 24:387-393. (Pubitemid 44215184)
21. Hofbauer R, Moser D, Frass M, Oberbauer R, Kaye AD, Wagner O, Kapiotis S, Druml W: Effect of anticoagulation on blood membrane interactions during hemodialysis. Kidney Int 1999; 56: 1578-1583. (Pubitemid 29451266)
22. Stefoni S, Cianciolo G, Donati G, Colì L, La Manna G, Raimondi C, Dalmastri V, Orlandi V, D'Addio F: Standard heparin versus low-molecular-weight heparin. A medium-term comparison in haemodialysis. Nephron 2002; 92: 589-600.
23. Coli L, De Sanctis LB, Feliciangeli G, Iannelli S, Scolari MP, Todeschini P, Tumietto F, Costigliola P, Chiodo F: Dialysis membrane biocompatibility: effects on cellular elements. Nephrol Dial Transplant 1995; 10(suppl 10):27-32. (Pubitemid 26031908)